Featuring Adam Friedman, MD, FAAD Dr. Adam Friedman returned for the afternoon product theater to discuss atopic dermatitis (AD) and treatment with Dupixent. Dupixent is a treatment for moderate to severe atopic dermatitis in patients 12 years of age or older whose disease is not adequately controlled with topical prescription therapies. Dr. Friedman reports “atopic …
Atopic eczema is a relatively common condition in infants, but fears about the side effects of the most common first-line therapy may lead to parents undertreating their babies. While corticosteroids do have some side effects, a recent article stated that these have been amplified in the media and subsequently spawned an outsized fear of steroids. …
Childhood eczema is common and causes a significant impact on the children and families that are coping with the condition. A typical treatment regimen includes emollient therapy, whether by use of emollient soap substitutes, leave-on emollients, or bath additives that are designed to be added to bath water and thought to leave a film of …